1. The goal glucose range in hospitalized patients on insulin therapy, as recommended by the American Diabetes Association (ADA), should be:
A. Less than 100 mg/dL as possible prior to meals
B. Between 140 mg/dL and 180 mg/dL
C. Achieved using a sliding-scale subcutaneous (SC) insulin regimen
D. Less than 200 mg/dL
2. Non-critically ill patients with good nutritional intake will typically require________insulin orders to effectively attain glycemic goals while minimizing the risk of hypoglycemia.
A. 1
B. 2
C. 3
D. 4
3. Although the insulin required for patients varies substantially, when initiating subcutaneous insulin therapy for most patients in the inpatient setting, a conservative standard starting estimate for a total daily dose is:
A. 0.1 – 0.3 U/kg
B. 0.2 – 0.5 U/kg
C. 0.5 – 1.0 U/kg
D. 0 – 1.5 U/kg
4. When initiating subcutaneous insulin therapy in the inpatient setting, it is important to consider which of the following factor(s)?
A. The patient's prior home regimen and level of glucose control (if applicable)
B. Nutritional and clinical status
C. Concomitant medications
D. All of the above
5. Many factors play into the regimen, including home medications, nutritional status, drugs, etc. Adjustments to insulin regimens in response to clinical considerations are:
A. Not typically required for hospitalized patients
B. Occasionally required for hospitalized patients
C. Frequently required for hospitalized patients
D. Not standard of care for hospitalized patients
6. Which one of the following is a risk factor for hypoglycemia?
A. Awake and conversant
B. Nothing-by-mouth status
C. Frequent glucose monitoring
D. Consistent nutritional intake
7. Which of the following is the threshold for hypoglycemia as defined by the American Diabetes Association (ADA)?
A. <140 mg/dL
B. <70 mg/dL
C. <100 mg/dL
D. <180 mg/dL
8. The first step to transitioning from an intravenous to an subcutaneous insulin regimen is:
A. Estimate the total daily dose of subcutaneous insulin to use
B. Determine the type of insulin to use
C. Order sliding-scale insulin only
D. Stop insulin infusion and follow glucose levels without basal insulin
9. Patients newly diagnosed with diabetes should be discharged:
A. Always on basal, nutritional, and supplemental insulin
B. On a simple regimen and provided close follow-up with a dedicated provider who will closely look after their progress
C. Always on oral therapy
D. With no outpatient follow-up
10. Which of the following is a potential barrier to normoglycemia in hospitalized patients?
A. Use of insulin as primary management
B. Formulary restrictions from the steering committee
C. Metric assessments of protocols
D. Fear of hypoglycemia
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Will the information presented cause you to change your practice?
A. Yes
B. No
23. Are you committed to making these changes?
A. Yes
B. No
24. As a result of this activity, did you learn something new?
A. Yes
B. No
25. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
26. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20